Back
to sessions
Sep 28
Scientific
MODERATOR(S)
Keith Cengel, MD, PhD - University of Pennsylvania
Percy Lee, MD, FASTRO - City of Hope National Medical Center
Credits
| AMA PRA Category 1 Credits: | 1.00 |
| CAMPEP Credits: | 1.00 |
| MDCB Credits: | 1.00 |
Presentations
-
08:00am - 08:10am ET
Is Clinical Target Volume Necessary in Limited-Stage Small Cell Lung Cancer? A Large-Scale Comparative Study
Speaker: Xiaolong Wang, MS - Shandong Cancer Hospital and Institute, jinan -
08:10am - 08:20am ET
Prognostic Value of Post-Chemoradiotherapy Molecular Residual Disease (MRD) Clearance in Limited-Stage Small Cell Lung Cancer: A Prospective Longitudinal Study
Speaker: Feifei Teng, MD, PhD - Shandong Cancer Hospital and Institute, Jinan -
08:20am - 08:30am ET
Prognostic Value of Baseline Genomic Profiling and Longitudinal ctDNA-Based MRD Monitoring in Limited-Stage Small-Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Speaker: Chen Li, MD - Tianjin Medical University Cancer Institute and Hospital, Tianjin -
08:30am - 08:40am ET
Postoperative Hypofractionated Radiotherapy for Thymic Epithelial Tumors: Efficacy and Safety Results from a Prospective, Single-Center, Phase II Trial
Speaker: Zhihui Zhang, MD, PhD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing -
08:40am - 08:50am ET
Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects In Previously Treated Patients with Metastatic Thymic Tumors: A Single Institution, Phase II Trial
Speaker: Min Fan, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai -
08:50am - 09:00am ETSpeaker: Charles Simone, MD, FASTRO - New York Proton Center and Memorial Sloan Kettering Cancer Center, New York